ONCOGENESIS 润色咨询

Oncogenesis

出版年份：2015 年文章数：718 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：1.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-02-02 41004269

    偏重的研究方向：妇科肿瘤
    经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2020-02-09 cancer researcher

    等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱182hrqD2279(暂无昵称) 2019-11-14 发表::
    应该后面会发邮件给你    182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:
    应该后面会发邮件给你

    182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2020-02-16 1479944am90暂无昵称

    你了解这个杂志二审时间多长吗？cancer researcher 2020-02-09 00:00:00 发表:
    等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱

    cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2023-05-03 12046948m71(暂无昵称) 来自江苏省

    投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2023-01-02 1227923dm31(暂无昵称) 来自河南省

    请问这个杂志二审时间多久？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2020-02-21 1479944am90暂无昵称

    请问下oncogenesis二审多长时间？182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:
    3天

    182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天

    6

    展开6条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-10-30 ms2000000380475116

    请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-02-11 14738d37m30(暂无昵称)

    感谢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2021-10-26 叶落知秋225

    请问这个杂志一审有几个审稿人？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1189699, encodeId=f92c1189699c0, content=偏重的研究方向：妇科肿瘤<br>经验分享：问一下半个月从under consideration变成decision made，但是在under consideration的时候收到过一封送审的邮件 但是没有收到被拒的邮件 这个decision made是被拒了吗 稿件也变成了post decision manuscript 有投过稿子的大神分享下经验吗 感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2abe3035903, createdName=41004269, createdTime=Wed Feb 02 13:52:55 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584437, encodeId=d6d958443e95, content=等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱<span class="quote">182hrqD2279(暂无昵称) 2019-11-14 发表::<br>应该后面会发邮件给你</span><span class="quote">182hrqD2279(暂无昵称) 2019-11-14 00:00:00 发表:<br>应该后面会发邮件给你</span>, beContent=182hrqD2279(暂无昵称) 2019-11-14 发表:: 应该后面会发邮件给你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201113/c8f91cf147524ce19dd6cbf419bc4da1/19a0a8378b3945ea9e0a0a98daa778b7.jpg, createdBy=55e65276226, createdName=cancer researcher, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584819, encodeId=d45b58481956, content=你了解这个杂志二审时间多长吗？<span class="quote">cancer researcher 2020-02-09 00:00:00 发表:<br>等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱</span>, beContent=cancer researcher 2020-02-09 00:00:00 发表: 等邮件，如果送审。这个杂志会实时发邮件到通讯作者邮箱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Sun Feb 16 00:00:00 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2129894, encodeId=593b2129894b7, content=投稿后审查通过，发邮件通知我先由编辑部内审再送外审，请问投过的同仁告知下内审一般多久。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=885a2167836, createdName=12046948m71(暂无昵称), createdTime=Wed May 03 18:41:46 CST 2023, time=2023-05-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2108479, encodeId=f5f121084e9d6, content=请问这个杂志二审时间多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08512334522, createdName=1227923dm31(暂无昵称), createdTime=Mon Jan 02 09:45:07 CST 2023, time=2023-01-02, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=585137, encodeId=f70758513e9f, content=请问下oncogenesis二审多长时间？<span class="quote">182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表:<br>3天</span>, beContent=182hrqD2279(暂无昵称) 2020-01-01 00:00:00 发表: 3天, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1395229461, createdName=1479944am90暂无昵称, createdTime=Fri Feb 21 00:00:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097406, encodeId=cd90209e40609, content=请问上传QPCR原始数据是最原始机器上下载的原始文件还自己是整理后包括CT值的的EXCEL文件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b195530495, createdName=ms2000000380475116, createdTime=Sun Oct 30 01:13:04 CST 2022, time=2022-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192208, encodeId=27da119220832, content=感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2bb5199994, createdName=14738d37m30(暂无昵称), createdTime=Fri Feb 11 10:02:50 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064131, encodeId=fe881064131db, content=请问这个杂志一审有几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e25500028, createdName=叶落知秋225, createdTime=Tue Oct 26 16:32:40 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179443, encodeId=841e11e9443d6, content=荣升中科院升级版1区，有点意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Fri Dec 31 23:10:49 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2021-12-31 1811e984f8m

    荣升中科院升级版1区，有点意外。

    1

    展开1条回复
共181条页码: 2/19页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分